Halaven Demonstrates Survival Benefit and Becomes First FDA-Approved Chemotherapy for Liposarcoma
News
According to a U.S. Food and Drug Administration (FDA) press release, the agency has just approved Halaven (eribulin mesylate) – a specific type of chemotherapy for the treatment of liposarcoma ... Read more